Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CSPC Pharmaceutical Group...

    OTC: CHJTF · Real-Time Price · USD
    1.27
    0.00 (0.00%)
    At close: Aug 05, 2025, 12:35 PM
    1.27
    0.00%
    After-hours: Aug 13, 2025, 08:00 PM EDT

    CSPC Pharmaceutical Balance Sheet Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 6.78B 12.02B 11.56B 11.36B
    Short-Term Investments
    		 1.47B 1.08B 4.01B 1.77B
    Long-Term Investments
    		 4.8B 5.13B 4.25B 4.42B
    Other Long-Term Assets
    		 1.53B 264.66M 630.6M 513.63M
    Receivables
    		 9.94B 10.13B 7.62B 7.98B
    Inventory
    		 3.13B 3.14B 2.87B 3.03B
    Other Current Assets
    		 362.35M n/a 6.84B 6.55B
    Total Current Assets
    		 21.89B 26.74B 26.9B 24.88B
    Property-Plant & Equipment
    		 13.08B 13.5B 12.32B 11.7B
    Goodwill & Intangibles
    		 2.84B 2.43B 2.67B 939.25M
    Total Long-Term Assets
    		 22.5B 21.51B 20B 17.62B
    Total Assets
    		 44.39B 46.28B 46.9B 42.5B
    Account Payables
    		 2.61B 2.84B 2.01B 1.62B
    Deferred Revenue
    		 n/a -8.31M 897.58M 524.05M
    Short-Term Debt
    		 392.2M 450.22M 331.83M n/a
    Other Current Liabilities
    		 945.86M 827.12M 1.86B 645.75M
    Total Current Liabilities
    		 9.63B 10.18B 10.06B 8.84B
    Long-Term Debt
    		 n/a n/a 28.95M n/a
    Other Long-Term Liabilities
    		 407.81M 399.68M 76.35M 12.42M
    Total Long-Term Liabilities
    		 888.67M 1.08B 1.01B 534.69M
    Total Liabilities
    		 10.52B 11.26B 11.07B 9.37B
    Total Debt
    		 507.33M 706.9M 654.05M 115.04M
    Common Stock
    		 11.03B 12B 12.24B 13.33B
    Retained Earnings
    		 23.34B 28.87B 23.73B 21.13B
    Comprehensive Income
    		 n/a -7.46B -1.97B -2.57B
    Shareholders Equity
    		 32.26B 33.2B 33.9B 31.79B
    Total Investments
    		 6.27B 6.31B 8.26B 6.18B

    Add to Watchlist